FDA Guidance on Discontinuation of Donor Deferral for West Nile Virus Infection

Summary

The FDA is announcing the availability of a document that removes a donor deferral recommendation related to West Nile Virus (WNV) infection, effective immediately, due to the approaching season. This guidance affects blood components intended for transfusion and further manufacturing into injectable products.